Data / Form D filings / Algorithm Sciences, Inc.
Algorithm Sciences, Inc.: Form D filings
Algorithm Sciences, Inc., a biotechnology company in New York, NY, filed 5 Form D notices with the SEC between 2019 and 2024. The latest, on April 12, 2024, reports $350,000 sold of a $23.5 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 575 5TH AVENUE, 14TH FLOOR, New York, NY, 10017
- Phone
- (646) 335-5923
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1776575
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 12, 2024 | New notice | $23,500,000 | $350,000 | $23,150,000 | 2 | Apr 9, 2024 | sec.gov |
| Apr 7, 2023 | New notice | $5,000,000 | $684,651 | $4,315,349 | 35 | May 3, 2022 | sec.gov |
| Dec 28, 2021 | New notice | $7,000,000 | $1,135,000 | $5,865,000 | 10 | Dec 13, 2021 | sec.gov |
| Mar 26, 2021 | New notice | $10,000,000 | $2,899,500 | $7,100,500 | 39 | Mar 12, 2021 | sec.gov |
| Oct 23, 2019 | New notice | $6,000,000 | $2,087,980 | $3,912,020 | 23 | Oct 10, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Tilton | Executive Officer, Director | |
| David Cavalier | Executive Officer | |
| Kamal Mubark | Director | |
| James Ahern | Director | |
| Matthew Duffy | Director | |
| Jeffrey O'Donnell | Director | |
| Anthony Zook | Director | |
| Gary Gemignani | Director | |
| Patrick Gallagher | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Apr 8, 2024 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Algorithm Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.